{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:15:43Z","timestamp":1787066143026,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The risk of SARS-COV-2 transmission is relatively high during dental procedures. A study was conducted to investigate the effects of mouthwashes on SARS-COV-2 viral load reduction in the oral cavity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was performed in PubMed, EMBASE, Scopus, Web of Science, and Cochrane library for relevant studies up to 20 July, 2022. Randomized and non-randomized clinical trial and quasi-experimental studies evaluating patients with Covid-19 infection (patients) who used mouthwashes (intervention) compared to the same patients before using the mouthwash (comparison) for reducing the SARS-COV-2 load or increasing the cycle threshold (Ct) value (outcome) were searched according to PICO components. Three independent reviewers conducted literature screening and data extraction. The Modified Downs and Black checklist was used for quality assessment. A meta-analysis was performed with a random effects model in the Revman 5.4.1software using the mean difference (MD) of cycle threshold (Ct) values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1653 articles, 9 with a high methodological quality were included. A meta-analysis indicated that 1% Povidone-iodine (PVP-I) was an effective mouthwash for reducing the SARS-COV-2 viral load [MD 3.61 (95% confidence interval 1.03, 6.19)]. Cetylpyridinium chloride (CPC) [MD 0.61 (95% confidence interval -1.03, 2.25)] and Chlorhexidine gluconate (CHX) [MD -0.04 95% confidence interval (-1.20, 1.12)] were not effective against SARS-COV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Using mouthwashes containing PVP-I may be recommended for reducing the SARS-COV-2 viral load in the oral cavity of patients before and during dental procedures, while the evidence is not sufficient for such effects for CPC and CHX-containing mouthwashes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-023-03126-4","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T10:03:38Z","timestamp":1688378618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness of mouthwashes on reducing SARS-CoV-2 viral load in oral cavity: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Tayebe","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Shamshiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Alebouyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin Z.","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"issue":"8","key":"3126_CR1","doi-asserted-by":"publisher","first-page":"e1008762","DOI":"10.1371\/journal.ppat.1008762","volume":"16","author":"A Mittal","year":"2020","unstructured":"Mittal A, Manjunath K, Ranjan RK, Kaushik S, Kumar S, Verma V. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2. PLoS Pathog. 2020;16(8):e1008762.","journal-title":"PLoS Pathog"},{"issue":"5","key":"3126_CR2","doi-asserted-by":"publisher","first-page":"102618","DOI":"10.1016\/j.amjoto.2020.102618","volume":"41","author":"MM Khan","year":"2020","unstructured":"Khan MM, Parab SR, Paranjape M. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic. Am J Otolaryngol. 2020;41(5):102618.","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"3126_CR3","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","volume":"24","author":"W Ni","year":"2020","unstructured":"Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24(1):422.","journal-title":"Crit Care"},{"issue":"2","key":"3126_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/his.14160","volume":"77","author":"AN Duarte-Neto","year":"2020","unstructured":"Duarte-Neto AN, Monteiro RAA, da Silva LFF, Malheiros D, de Oliveira EP, Theodoro-Filho J, et al. Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy. Histopathology. 2020;77(2):186\u201397.","journal-title":"Histopathology"},{"issue":"2","key":"3126_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631\u20137.","journal-title":"J Pathol"},{"issue":"1","key":"3126_CR6","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.jinf.2020.04.005","volume":"81","author":"L Azzi","year":"2020","unstructured":"Azzi L, Carcano G, Gianfagna F, Grossi P, Gasperina DD, Genoni A, et al. Saliva is a reliable tool to detect SARS-CoV-2. J Infect. 2020;81(1):e45\u201350.","journal-title":"J Infect"},{"issue":"2","key":"3126_CR7","first-page":"89","volume":"23","author":"XH Zhang","year":"2020","unstructured":"Zhang XH, Ling JQ. Guidelines on the Prevention and Control of Disease in Dental Practice during the Coronavirus Outbreak. Chin J Dent Res. 2020;23(2):89\u201394.","journal-title":"Chin J Dent Res"},{"issue":"1","key":"3126_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41368-020-0075-9","volume":"12","author":"X Peng","year":"2020","unstructured":"Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020;12(1):9.","journal-title":"Int J Oral Sci"},{"issue":"1","key":"3126_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/thoraxjnl-2020-215042","volume":"76","author":"SH Ra","year":"2021","unstructured":"Ra SH, Lim JS, Kim GU, Kim MJ, Jung J, Kim SH. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection. Thorax. 2021;76(1):61\u20133.","journal-title":"Thorax"},{"key":"3126_CR10","doi-asserted-by":"crossref","unstructured":"Gostic K, Gomez AC, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife. 2020;9.","DOI":"10.7554\/eLife.55570"},{"key":"3126_CR11","doi-asserted-by":"crossref","unstructured":"Siles-Garcia AA, Alzamora-Cepeda AG, Atoche-Socola KJ, Pe\u00f1a-Soto C, Arriola-Guill\u00e9n LE. Biosafety for Dental Patients During Dentistry Care After COVID-19: A Review of the Literature. Disaster Med Public Health Prep. 2020:1\u20136.","DOI":"10.1017\/dmp.2020.252"},{"key":"3126_CR12","doi-asserted-by":"crossref","unstructured":"Carrouel F, Conte MP, Fisher J, Gon\u00e7alves LS, Dussart C, Llodra JC, et al. COVID-19: A Recommendation to Examine the Effect of Mouthrinses with \u03b2-Cyclodextrin Combined with Citrox in Preventing Infection and Progression. Journal of clinical medicine. 2020;9(4).","DOI":"10.3390\/jcm9041126"},{"issue":"11","key":"3126_CR13","doi-asserted-by":"publisher","first-page":"e0207262","DOI":"10.1371\/journal.pone.0207262","volume":"13","author":"A Ardizzoni","year":"2018","unstructured":"Ardizzoni A, Pericolini E, Paulone S, Orsi CF, Castagnoli A, Oliva I, et al. In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. PLoS ONE. 2018;13(11):e0207262.","journal-title":"PLoS ONE"},{"issue":"4","key":"3126_CR14","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00784-016-1876-2","volume":"21","author":"YMM Fernandez","year":"2017","unstructured":"Fernandez YMM, Exterkate RAM, Buijs MJ, Crielaard W, Zaura E. Effect of mouthwashes on the composition and metabolic activity of oral biofilms grown in vitro. Clin Oral Investig. 2017;21(4):1221\u201330.","journal-title":"Clin Oral Investig"},{"issue":"8","key":"3126_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/infdis\/jiaa471","volume":"222","author":"TL Meister","year":"2020","unstructured":"Meister TL, Br\u00fcggemann Y, Todt D, Conzelmann C, M\u00fcller JA, Gro\u00df R, et al. Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2020;222(8):1289\u201392.","journal-title":"J Infect Dis"},{"issue":"2","key":"3126_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40121-018-0200-7","volume":"7","author":"M Eggers","year":"2018","unstructured":"Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle\/Mouthwash Against Respiratory and Oral Tract Pathogens. Infect Dis Ther. 2018;7(2):249\u201359.","journal-title":"Infect Dis Ther"},{"issue":"3","key":"3126_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s40121-020-00316-3","volume":"9","author":"DE Anderson","year":"2020","unstructured":"Anderson DE, Sivalingam V, Kang AEZ, Ananthanarayanan A, Arumugam H, Jenkins TM, et al. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. Infect Dis Ther. 2020;9(3):669\u201375.","journal-title":"Infect Dis Ther"},{"key":"3126_CR18","doi-asserted-by":"crossref","unstructured":"Hassandarvish P, Tiong V, Mohamed NA, Arumugam H, Ananthanarayanan A, Qasuri M, et al. In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice. Br Dent J. 2020:1\u20134.","DOI":"10.1038\/s41415-020-2402-0"},{"issue":"6","key":"3126_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/jopr.13209","volume":"29","author":"AS Bidra","year":"2020","unstructured":"Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse. J Prosthodont. 2020;29(6):529\u201333.","journal-title":"J Prosthodont"},{"issue":"10","key":"3126_CR20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-34.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"3126_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jech.52.6.377","volume":"52","author":"SH Downs","year":"1998","unstructured":"Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377\u201384.","journal-title":"J Epidemiol Community Health"},{"issue":"7650","key":"3126_CR22","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924.","journal-title":"BMJ"},{"issue":"10","key":"3126_CR23","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1007\/s00784-020-03549-1","volume":"24","author":"MJ Gottsauner","year":"2020","unstructured":"Gottsauner MJ, Michaelides I, Schmidt B, Scholz KJ, Buchalla W, Widbiller M, et al. A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2. Clin Oral Investig. 2020;24(10):3707\u201313.","journal-title":"Clin Oral Investig"},{"key":"3126_CR24","doi-asserted-by":"crossref","unstructured":"Mohamed NA, Baharom N, Sulaiman WSW, Rashid ZZ, Ken WK, Ali UK, et al. EARLY VIRAL CLEARANCE AMONG COVID-19 PATIENTS WHEN GARGLING WITH POVIDONE-IODINE AND ESSENTIAL OILS \u2013 A CLINICAL TRIAL. medRxiv. 2020:2020.09.07.20180448.","DOI":"10.1101\/2020.09.07.20180448"},{"key":"3126_CR25","doi-asserted-by":"crossref","unstructured":"Mukhtar K, Qassim S, Al Qahtani SA, Danjuma MI-M, Mohamedali M, Farhan HA, et al. A randomized trial on the regular use of potent mouthwash in COVID-19 treatment. medRxiv. 2021:2020.11.27.20234997.","DOI":"10.1101\/2020.11.27.20234997"},{"key":"3126_CR26","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez Lamas L, Diz Dios P, P\u00e9rez Rodr\u00edguez MT, Del Campo P\u00e9rez V, Cabrera Alvargonzalez JJ, L\u00f3pez Dom\u00ednguez AM, et al. Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests. Oral Dis. 2020.","DOI":"10.1111\/odi.13526"},{"issue":"20","key":"3126_CR27","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.3346\/jkms.2020.35.e195","volume":"35","author":"JG Yoon","year":"2020","unstructured":"Yoon JG, Yoon J, Song JY, Yoon SY, Lim CS, Seong H, et al. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva. J Korean Med Sci. 2020;35(20):e195.","journal-title":"J Korean Med Sci"},{"issue":"2","key":"3126_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s15010-020-01563-9","volume":"49","author":"CJ Seneviratne","year":"2021","unstructured":"Seneviratne CJ, Balan P, Ko KKK, Udawatte NS, Lai D, Ng DHL, et al. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore. Infection. 2021;49(2):305\u201311.","journal-title":"Infection"},{"issue":"10","key":"3126_CR29","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.cmi.2021.05.028","volume":"27","author":"F Carrouel","year":"2021","unstructured":"Carrouel F, Valette M, Gadea E, Esparcieux A, Illes G, Langlois ME, et al. Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial. Clin Microbiol Infect. 2021;27(10):1494\u2013501.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"3126_CR30","doi-asserted-by":"publisher","first-page":"e07346","DOI":"10.1016\/j.heliyon.2021.e07346","volume":"7","author":"FP Eduardo","year":"2021","unstructured":"Eduardo FP, Corr\u00eaa L, Heller D, Daep CA, Benitez C, Malheiros Z, et al. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial. Heliyon. 2021;7(6):e07346.","journal-title":"Heliyon"},{"issue":"11","key":"3126_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.adaj.2021.05.021","volume":"152","author":"P Chaudhary","year":"2021","unstructured":"Chaudhary P, Melkonyan A, Meethil A, Saraswat S, Hall DL, Cottle J, et al. Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load: A randomized controlled trial. J Am Dent Assoc. 2021;152(11):903\u20138.","journal-title":"J Am Dent Assoc"},{"key":"3126_CR32","doi-asserted-by":"publisher","unstructured":"Cyril Vitug L, Santiaguel J, Angelica Exconde MA, Ma Teresa Tricia B. Oral Gargle of Ethanol-Based Mouthwash Solution and Its Effects on Adult Patients with Mild Covid-19 Infection: An Open Label-Randomized Controlled Trial: Chest. 2021 Oct;160(4):A2504. doi: https:\/\/doi.org\/10.1016\/j.chest.2021.08.014. Epub 2021 Oct 11.","DOI":"10.1016\/j.chest.2021.08.014"},{"key":"3126_CR33","doi-asserted-by":"crossref","unstructured":"Anderson ER, Patterson EI, Richards S, Pitol AK, Edwards T, Wooding D, et al. CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva. Journal of medical microbiology. 2022;71(2).","DOI":"10.1099\/jmm.0.001508"},{"issue":"1","key":"3126_CR34","doi-asserted-by":"publisher","first-page":"14050","DOI":"10.1038\/s41598-022-18367-6","volume":"12","author":"R Takeda","year":"2022","unstructured":"Takeda R, Sawa H, Sasaki M, Orba Y, Maishi N, Tsumita T, et al. Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2. Sci Rep. 2022;12(1):14050.","journal-title":"Sci Rep"},{"issue":"1","key":"3126_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/jisp.jisp_824_20","volume":"25","author":"A Jain","year":"2021","unstructured":"Jain A, Grover V, Singh C, Sharma A, Das DK, Singh P, et al. Chlorhexidine: An effective anticovid mouth rinse. J Indian Soc Periodontol. 2021;25(1):86\u20138.","journal-title":"J Indian Soc Periodontol"},{"issue":"7","key":"3126_CR36","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1002\/jmv.26954","volume":"93","author":"YH Huang","year":"2021","unstructured":"Huang YH, Huang JT. Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients. J Med Virol. 2021;93(7):4370\u20133.","journal-title":"J Med Virol"},{"issue":"5","key":"3126_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jormas.2020.11.001","volume":"122","author":"JMP Filho","year":"2021","unstructured":"Filho JMP, Spanemberg JC, Cardoso JA. Coronavirus pandemic: is H(2)O(2) mouthwash going to overcome the chlorhexidine in dental practices? J Stomatol Oral Maxillofac Surg. 2021;122(5):527\u20138.","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"8","key":"3126_CR38","first-page":"1","volume":"16","author":"Horacio Almansa-Reyes","year":"2021","unstructured":"Almanza-Reyes H, Moreno S, Plascencia-L\u00f3pez I, Alvarado-Vera M, Patr\u00f3n-Romero L, Borrego B, Reyes-Escamilla A, Valencia-Manzo D, Brun A, Pestryakov A, Bogdanchikova N. Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo. PLoS One. 2021;16(8):e0256401.\u00a0","journal-title":"PLoS One"},{"issue":"1","key":"3126_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijid.2005.02.003","volume":"10","author":"E Keyaerts","year":"2006","unstructured":"Keyaerts E, Vijgen L, Maes P, Duson G, Neyts J, Van Ranst M. Viral load quantitation of SARS-coronavirus RNA using a one-step real-time RT-PCR. Int J Infect Dis. 2006;10(1):32\u20137.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"3126_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1601-5037.2010.00492.x","volume":"9","author":"N Hossainian","year":"2011","unstructured":"Hossainian N, Slot DE, Afennich F, Van der Weijden GA. The effects of hydrogen peroxide mouthwashes on the prevention of plaque and gingival inflammation: a systematic review. Int J Dent Hyg. 2011;9(3):171\u201381.","journal-title":"Int J Dent Hyg"},{"issue":"20","key":"3126_CR41","first-page":"30267","volume":"S2468\u20137855","author":"JMP Filho","year":"2020","unstructured":"Filho JMP, Spanemberg JC, Cardoso JA. Coronavirus pandemic: is H(2)O(2) mouthwash going to overcome the chlorhexidine in dental practices? J Stomatol Oral Maxillofac Surg. 2020;S2468\u20137855(20):30267\u201376.","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"1","key":"3126_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0030-4220(58)90228-7","volume":"11","author":"FW Kraus","year":"1958","unstructured":"Kraus FW, Perry WI, Nickerson JF. Salivary catalase and peroxidase values in normal subjects and in persons with periodontal disease. Oral Surg Oral Med Oral Pathol. 1958;11(1):95\u2013102.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"9","key":"3126_CR43","doi-asserted-by":"publisher","first-page":"e00682","DOI":"10.1128\/AAC.00682-20","volume":"64","author":"D Lepelletier","year":"2020","unstructured":"Lepelletier D, Maillard JY, Pozzetto B, Simon A. Povidone Iodine: Properties, Mechanisms of Action, and Role in Infection Control and Staphylococcus aureus Decolonization. Antimicrob Agents Chemother. 2020;64(9):e00682-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"3126_CR44","doi-asserted-by":"crossref","unstructured":"J.M. Lachapelle OC, AF. Casado, B. Leroy, G. Micali, D. Tennstedt, J. Lambert. Antiseptics in the era of bacterial resistance: a focus on povidone iodine. clinical practie. 2013;10(5):579\u201392.","DOI":"10.2217\/cpr.13.50"},{"issue":"2","key":"3126_CR45","first-page":"31","volume":"48","author":"MA Domingo","year":"1996","unstructured":"Domingo MA, Farrales MS, Loya RM, Pura MA, Uy H. The effect of 1% povidone iodine as a pre-procedural mouthrinse in 20 patients with varying degrees of oral hygiene. J Philipp Dent Assoc. 1996;48(2):31\u20138.","journal-title":"J Philipp Dent Assoc"},{"key":"3126_CR46","doi-asserted-by":"publisher","first-page":"102046","DOI":"10.1016\/j.jddst.2020.102046","volume":"60","author":"M Kurakula","year":"2020","unstructured":"Kurakula M, Rao GSNK. Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition. J Drug Deliv Sci Technol. 2020;60:102046.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"3126_CR47","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/hed.26200","volume":"42","author":"HS Parhar","year":"2020","unstructured":"Parhar HS, Tasche K, Brody RM, Weinstein GS, O\u2019Malley BW Jr, Shanti RM, et al. Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery. Head Neck. 2020;42(6):1268\u201372.","journal-title":"Head Neck"},{"issue":"6","key":"3126_CR48","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jpc.12232","volume":"49","author":"PEA Gray","year":"2013","unstructured":"Gray PEA, Katelaris CH, Lipson D. Recurrent anaphylaxis caused by topical povidone-iodine (Betadine). J Paediatr Child Health. 2013;49(6):506\u20137.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"3126_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12903-017-0400-7","volume":"17","author":"M Haydari","year":"2017","unstructured":"Haydari M, Bardakci AG, Koldsland OC, Aass AM, Sandvik L, Preus HR. Comparing the effect of 0.06% -, 0.12% and 0.2% Chlorhexidine on plaque, bleeding and side effects in an experimental gingivitis model: a parallel group, double masked randomized clinical trial. BMC Oral Health. 2017;17(1):118.","journal-title":"BMC Oral Health"},{"issue":"3","key":"3126_CR50","first-page":"Cd008676","volume":"3","author":"P James","year":"2017","unstructured":"James P, Worthington HV, Parnell C, Harding M, Lamont T, Cheung A, et al. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev. 2017;3(3):Cd008676.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3126_CR51","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/00220345900690030901","volume":"69","author":"D Bernstein","year":"1990","unstructured":"Bernstein D, Schiff G, Echler G, Prince A, Feller M, Briner W. In vitro virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse. J Dent Res. 1990;69(3):874\u20136.","journal-title":"J Dent Res"},{"issue":"2","key":"3126_CR52","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.4317\/jced.57406","volume":"13","author":"BL Cavalcante-Le\u00e3o","year":"2021","unstructured":"Cavalcante-Le\u00e3o BL, de Araujo CM, Basso IB, Schroder AG, Guariza-Filho O, Ravazzi GC, et al. Is there scientific evidence of the mouthwashes effectiveness in reducing viral load in Covid-19? A systematic review. J Clin Exp Dent. 2021;13(2):e179\u201389.","journal-title":"J Clin Exp Dent"},{"issue":"1","key":"3126_CR53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.sdentj.2017.12.004","volume":"30","author":"FA Alshehri","year":"2018","unstructured":"Alshehri FA. The use of mouthwash containing essential oils (LISTERINE\u00ae) to improve oral health: A systematic review. Saudi Dent J. 2018;30(1):2\u20136.","journal-title":"Saudi Dent J"},{"issue":"4","key":"3126_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ajodo.2011.01.022","volume":"140","author":"Y Chen","year":"2011","unstructured":"Chen Y, Wong RW, Seneviratne CJ, H\u00e4gg U, McGrath C, Samaranayake LP. Comparison of the antimicrobial activity of Listerine and Corsodyl on orthodontic brackets in vitro. Am J Orthod Dentofacial Orthop. 2011;140(4):537\u201342.","journal-title":"Am J Orthod Dentofacial Orthop"},{"issue":"4","key":"3126_CR55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1600-051X.2005.00673.x","volume":"32","author":"TF Meiller","year":"2005","unstructured":"Meiller TF, Silva A, Ferreira SM, Jabra-Rizk MA, Kelley JI, DePaola LG. Efficacy of Listerine Antiseptic in reducing viral contamination of saliva. J Clin Periodontol. 2005;32(4):341\u20136.","journal-title":"J Clin Periodontol"},{"issue":"1","key":"3126_CR56","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1038\/sj.bdj.2010.1224","volume":"210","author":"SJ Hooper","year":"2011","unstructured":"Hooper SJ, Lewis MA, Wilson MJ, Williams DW. Antimicrobial activity of Citrox bioflavonoid preparations against oral microorganisms. Br Dent J. 2011;210(1):E22.","journal-title":"Br Dent J"},{"key":"3126_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113962","volume":"177","author":"M Zou","year":"2020","unstructured":"Zou M, Liu H, Li J, Yao X, Chen Y, Ke C, et al. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection. Biochem Pharmacol. 2020;177: 113962.","journal-title":"Biochem Pharmacol"},{"key":"3126_CR58","doi-asserted-by":"crossref","unstructured":"Lalani S, Poh CL. Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71). Viruses. 2020;12(2).","DOI":"10.3390\/v12020184"},{"issue":"2","key":"3126_CR59","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1006\/bbrc.2000.3485","volume":"276","author":"BQ Li","year":"2000","unstructured":"Li BQ, Fu T, Dongyan Y, Mikovits JA, Ruscetti FW, Wang JM. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun. 2000;276(2):534\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3126_CR60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.32607\/20758251-2019-11-3-20-30","volume":"11","author":"EP Goncharova","year":"2019","unstructured":"Goncharova EP, Kostyro YA, Ivanov AV, Zenkova MA. A Novel Sulfonated Derivative of \u03b2-Cyclodextrin Effectively Inhibits Influenza A Virus Infection in vitro and in vivo. Acta Naturae. 2019;11(3):20\u201330.","journal-title":"Acta Naturae"},{"issue":"11","key":"3126_CR61","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/jcpe.12158","volume":"40","author":"X Costa","year":"2013","unstructured":"Costa X, Laguna E, Herrera D, Serrano J, Alonso B, Sanz M. Efficacy of a new mouth rinse formulation based on 0.07% cetylpyridinium chloride in the control of plaque and gingivitis: a 6-month randomized clinical trial. J Clin Periodontol. 2013;40(11):1007\u201315.","journal-title":"J Clin Periodontol"},{"issue":"6","key":"3126_CR62","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3390\/jcm9061833","volume":"9","author":"K Gurzawska-Comis","year":"2020","unstructured":"Gurzawska-Comis K, Becker K, Brunello G, Gurzawska A, Schwarz F. Recommendations for Dental Care during COVID-19 Pandemic. J Clin Med. 2020;9(6):1833.","journal-title":"J Clin Med"},{"issue":"2","key":"3126_CR63","first-page":"252","volume":"2","author":"DL Popkin","year":"2017","unstructured":"Popkin DL, Zilka S, Dimaano M, Fujioka H, Rackley C, Salata R, et al. Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activity Against Influenza Viruses in vitro and in vivo. Pathog Immun. 2017;2(2):252\u201369.","journal-title":"Pathog Immun"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-03126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-023-03126-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-03126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T10:04:42Z","timestamp":1688378682000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-023-03126-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3126"],"URL":"https:\/\/doi.org\/10.1186\/s12903-023-03126-4","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"31 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"443"}}